ETORICOXIB GLENMARK 120 TABLET Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

etoricoxib glenmark 120 tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - see ingredients - each tablet contains etoricoxib 120,0 mg

SALBUTAMOL 100 ug GLENMARK INHALER Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

salbutamol 100 ug glenmark inhaler

glenmark pharmaceuticals south africa (pty) ltd - inhaler - see ingredients - each actuation delivers salbutamol sulphate 100,0 ug

ABIRATERON 250 GLENMARK #N/A Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

abirateron 250 glenmark #n/a

glenmark pharmaceuticals south africa (pty) ltd - #n/a - not indicated - none

PEMETREXED 100 mg GLENMARK INFUSION Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

pemetrexed 100 mg glenmark infusion

glenmark pharmaceuticals south africa (pty) ltd - infusion - not indicated - none

PEMETREXED 500 mg GLENMARK INFUSION Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

pemetrexed 500 mg glenmark infusion

glenmark pharmaceuticals south africa (pty) ltd - infusion - not indicated - none

ESOMEPRAZOLE MAGNESIUM capsule, delayed release pellets USA - engelska - NLM (National Library of Medicine)

esomeprazole magnesium capsule, delayed release pellets

glenmark pharmaceuticals inc., usa - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - adults esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed ee in adults. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4- to 8- week course of esomeprazole magnesium delayed-release capsules may be considered. pediatric patients 12 years to 17 years of age esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) for the healing of ee in pediatric patients 12 years to 17 years of age. esomeprazole magnesium delayed-release capsules delayed-release capsules are indicated for the maintenance of healing of ee in adults. controlled studies do not extend beyond 6 months. adults esomeprazole magnesium delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. pediatric patients 12 years to 17 years of age esomeprazole magnes

ROSUVASTATIN 5 mg GLENMARK TABLET Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

rosuvastatin 5 mg glenmark tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - not indicated - none

ROSUVASTATIN 10 mg GLENMARK TABLET Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

rosuvastatin 10 mg glenmark tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - not indicated - none

ROSUVASTATIN 20 mg GLENMARK TABLET Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

rosuvastatin 20 mg glenmark tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - not indicated - none

ROSUVASTATIN 40 mg GLENMARK TABLET Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

rosuvastatin 40 mg glenmark tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - not indicated - none